NIKKOMYCIN X

ID: ALA612145

Max Phase: Preclinical

Molecular Formula: C20H25N5O10

Molecular Weight: 495.45

Molecule Type: Small molecule

Associated Items:

Representations

Synonyms (1): Nikkomycin X
Synonyms from Alternative Forms(1):

    Canonical SMILES:  C[C@@H]([C@H](N)C(=O)N[C@H](C(=O)O)[C@H]1OC(n2cc(C=O)nc2O)[C@H](O)[C@@H]1O)[C@H](O)c1ccc(O)cn1

    Standard InChI:  InChI=1S/C20H25N5O10/c1-7(13(28)10-3-2-9(27)4-22-10)11(21)17(31)24-12(19(32)33)16-14(29)15(30)18(35-16)25-5-8(6-26)23-20(25)34/h2-7,11-16,18,27-30H,21H2,1H3,(H,23,34)(H,24,31)(H,32,33)/t7-,11-,12-,13-,14-,15+,16+,18?/m0/s1

    Standard InChI Key:  AYXHZRVSIUJLAE-MNZXXUIQSA-N

    Associated Targets(non-human)

    Cutaneotrichosporon cutaneum 20 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Candida albicans 78123 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Staphylococcus chromogenes 18 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Molecule Features

    Natural Product: YesOral: NoChemical Probe: NoParenteral: No
    Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
    Chirality: NoAvailability: NoProdrug: No

    Drug Indications

    MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

    Mechanisms of Action

    Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

    Properties

    Molecular Weight: 495.45Molecular Weight (Monoisotopic): 495.1601AlogP: -2.61#Rotatable Bonds: 9
    Polar Surface Area: 250.58Molecular Species: ACIDHBA: 13HBD: 8
    #RO5 Violations: 2HBA (Lipinski): 15HBD (Lipinski): 9#RO5 Violations (Lipinski): 2
    CX Acidic pKa: 2.80CX Basic pKa: 7.77CX LogP: -4.17CX LogD: -4.31
    Aromatic Rings: 2Heavy Atoms: 35QED Weighted: 0.17Np Likeness Score: 1.05

    References

    1. Serpi M, Ferrari V, Pertusati F..  (2016)  Nucleoside Derived Antibiotics to Fight Microbial Drug Resistance: New Utilities for an Established Class of Drugs?,  59  (23): [PMID:27607900] [10.1021/acs.jmedchem.6b00325]

    Source